Trials of semaglutide in patients with Alzheimer’s and CagriSema in obese patients diabetes could give investors reason to be optimistic, Intron Health’s analysts said ...
The token’s sharp 11.5% price drop within 24 hours triggered the liquidation event. Despite these efforts, the market’s swift downturn triggered a liquidation of Egorov’s leveraged position.
This sharp sell-off followed the announcement from the US Federal Reserve, which triggered a wave of global market reactions. Dr. V K Vijayakumar, Chief Investment Strategist at Geojit Financial ...